Ascendis PharmaASND 
$148.751.47%24h
1.47%24h
Global rank1836
Market cap$8.37B
Change 7d24.94%
YTD Performance20.40%
SP500 benchmarkOutperform
P/E-17.40
P/S28.24
Revenue$296.45M
Earnings-$535.12M
Dividend yield-
Main Sector
Healthcare
EPS for Ascendis Pharma (ASND)
Ascendis Pharma has an EPS of $-8.55. In 2022, the company made an earnings per share (EPS) of $-10.4. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for ASND
-
Value:-
EPS history for Ascendis Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$8.55 | -17.79% |
| 2022 | -$10.40 | 48.57% |
| 2021 | -$7.00 | -15.46% |
| 2020 | -$8.28 | - |
View the highest EPS stocks
